• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Development of a new therapeutic approach against chemo-resistance of leukemic stem cells by bone marrow microenvironment

Research Project

  • PDF
Project/Area Number 22790907
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Hematology
Research InstitutionNational Hospital Organization Nagoya Medical Center

Principal Investigator

MIYATA Yasuhiko  独立行政法人国立病院機構(名古屋医療センター臨床研究センター), 血液内科, 医長 (40467303)

Project Period (FY) 2010 – 2012
Keywords血液腫瘍学
Research Abstract

Direct contact with bone marrow stromal cells provides CML-derived cell lines with dormancy similar to stem cells and induced-drug resistance. In these cells, up-regulation of anti-apoptotic protein BCL-2 and p53 was observed and was thought to lead to this resistance, suggesting that the molecular targeted therapy toward these proteins could be reasonable. Moreover, up-regulation of BCR-ABL protein and elongation of BCR-ABL mRNA were observed by contact with stromal cells. This indicates that cell-to-cell contact may be involved in post-transcriptional regulation of mRNA.

  • Research Products

    (19 results)

All 2012 2011 2010

All Journal Article (5 results) Presentation (12 results) Book (2 results)

  • [Journal Article] Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib.2012

    • Author(s)
      水野紘樹
    • Journal Title

      Leukemia.

      Volume: 26(10) Pages: 2269-76

  • [Journal Article] PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.2012

    • Author(s)
      萩原和美
    • Journal Title

      Genes Chromosomes Cancer.

      Volume: 51(36) Pages: 1024-36

  • [Journal Article] Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumorsuppressing ink4aarf locus.2012

    • Author(s)
      Liu Yan
    • Journal Title

      Science Signaling.

      Volume: 5 Pages: ra77

  • [Journal Article] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.2011

    • Author(s)
      倉橋信悟
    • Journal Title

      Oncogene.

      Volume: 30 Pages: 1822-30

  • [Journal Article] Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells.2010

    • Author(s)
      中尾典彦
    • Journal Title

      Am J Pathol.

      Volume: 177(2) Pages: 547-54

  • [Presentation] Cytotoxic Effect of Bendamustine Combined with Kinase Inhibitors in Hematologic Cell Lines.2012

    • Author(s)
      萩原和美
    • Organizer
      54^<th> American Society of Hematology Annual Meeting
    • Place of Presentation
      アトランタ(米国)
    • Year and Date
      20121208-11
  • [Presentation] Retrospective analysis of elderly patients with diffuse large B-cell lymphoma in rituximab era.2012

    • Author(s)
      宮田泰彦
    • Organizer
      第74回日本血液学会
    • Place of Presentation
      京都国際会議場(京都)
    • Year and Date
      20121019-21
  • [Presentation] Cytotoxicity of bendamustine combined with new gereration kinase inhibitors in lymphoid cell lines.2012

    • Author(s)
      萩原和美
    • Organizer
      第74回日本血液学会
    • Place of Presentation
      京都国際会議場(京都)
    • Year and Date
      20121019-21
  • [Presentation] 白血病細胞株においてBcl-2 の発現はストローマ細胞との接着により亢進し、薬剤耐性を誘導する.2012

    • Author(s)
      宮田泰彦
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌)
    • Year and Date
      20120919-21
  • [Presentation] 血液腫瘍細胞に対するベンダマスチンとキナーゼ阻害剤併用による殺細胞効果の検討.2012

    • Author(s)
      萩原和美
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌)
    • Year and Date
      20120919-21
  • [Presentation] Phase I Study of Clofarabine (JC0707) in Adult Japanese Patients with Acute Myeloid Leukemia (AML)2011

    • Author(s)
      山口高弘
    • Organizer
      53th ASH Annual Meeting
    • Place of Presentation
      サンディエゴ
    • Year and Date
      20111210-12
  • [Presentation] Clinical characteristics of adult AML refractory to the first induction therapy in our institute2011

    • Author(s)
      宮田泰彦
    • Organizer
      第73会日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      20111014-16
  • [Presentation] PAX5-PML Acts as a Dual Dominant-Negative Form of PAX5 and PML2010

    • Author(s)
      倉橋伸悟
    • Organizer
      52^<nd> ASH Annual Meeting
    • Place of Presentation
      オーランド
    • Year and Date
      20101204-07
  • [Presentation] Mesenchymal stem cells overexpressing a dominant negative inhibitor of CCL2 attenuated lung injury.2010

    • Author(s)
      齊藤繁紀
    • Organizer
      第72会日本血液学会学術集会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      20100924-26
  • [Presentation] PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.2010

    • Author(s)
      倉橋信悟
    • Organizer
      第72会日本血液学会学術集会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      20100924-26
  • [Presentation] Lymphoid transcription factor Pax5 is regulated by MAP kinase signal.2010

    • Author(s)
      安田貴彦
    • Organizer
      第72会日本血液学会学術集会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      20100924-26
  • [Presentation] Mast cells promote the growth of Hodgkin tumor by modifying the tumor microenvironment.2010

    • Author(s)
      中山享之
    • Organizer
      第72会日本血液学会学術集会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Year and Date
      20100924-26
  • [Book] 血液内科 第64巻1号特集血液腫瘍に対する重要な臨床試験の意義と診療・研究へのインパクトRituximab併用化学療法が奏効した進行期濾胞性リンパ腫患者に対するrituximab維持療法の比較試験 : PRIMA Study2012

  • [Book] 症例から学ぶメディカルオンコロジー 血液癌ホジキンリンパ腫(臨床病期II)ABVD 療法で長期寛解例2011

    • Publisher
      医学ジャーナル社

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi